[DOI] [PMC free article] [PubMed] [Google Scholar] 138.Cardoso P., Young K.G., Nair A.T.N., Hopkins R., McGovern A.P., Haider E., Karunaratne P., Donnelly L., Mateen B.A., Sattar N., et al
The role of decorin in cardiovascular diseases: more than just a decoration
Imunotherapy in combination with chemotherapy is emerging as a new standard of care in this setting, and the approval of Imfinzi offers an important new option for patients with mismatch repair deficient disease, Dave Fredrickson, executive vice president of the oncology business unit at AstraZeneca, said in a press release
Semaglutide with glycine is another combination that some compounding pharmacies offer, with glycine serving as a stabilizing amino acid
doi: 10.2460/ajvr.2003.64.1027
You may notice less GI discomfort around meals, though individual responses vary.*